CIK 0001534133 · Non-accelerated filer<br>Smaller reporting company
CalciMedica, Inc.
Sign in to watch- Ticker
- CALC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452120079
- Phone
- 858-952-5500
- Business address
- 505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA, 92037
- Former names
- CalciMedica, Inc. /DE/, GRAYBUG VISION, INC., GRAYBUG, Inc., GRAYBUG LLC
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy Chief Scientific Officer bought 1,000 shares at $3.96 ($3,960)
- 4 Open-market buy CHIEF BUSINESS OFFICER bought 1,500 shares at $3.78 ($5,663)
- 4 Open-market buy CHIEF BUSINESS OFFICER bought 1,500 shares at $3.37 ($5,055)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 1,000 shares at $3.40 ($3,400)
- 4 Open-market buy Director bought 4,500 shares at $2.87 ($12,915)
- 4 Open-market buy CHIEF BUSINESS OFFICER bought 2,000 shares at $2.88 ($5,760)
- 4 Open-market buy CHIEF BUSINESS OFFICER bought 6,500 shares at $2.43 ($15,810)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 2,500 shares at $2.47 ($6,175)
- 4 Open-market buy CHIEF BUSINESS OFFICER bought 5,000 shares at $1.60 ($8,024)
- 4 Open-market buy Chief Scientific Officer bought 1,000 shares at $1.85 ($1,850)
- 4 Open-market buy CHIEF BUSINESS OFFICER bought 4,500 shares at $1.44 ($6,483)
- S-8 POS Other Post-effective Amendment
- 8-K Event Executive or director change · Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $1.50 ($3,005)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 27 · 533 filings